Induction of micronuclei by 2-hydroxypyridine in water and elimination of solution genotoxicity by UVC (254nm) photolysis

Journal of Hazardous Materials

Volumn 197, Issue , 2011, Pages 137-143

  Skoutelis, Charalambos G ^a   Vlastos, Dimitris ^a   Kortsinidou, Marianna C ^a   Theodoridis, Ioannis T ^a   Papadaki, Maria I ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

2 Hydroxypyridine genotoxicity; 2 Pyridinol mineralisation; Genotoxicity; Micronucleus assay; Pyridines

Indexed keywords

2-HYDROXYPYRIDINE; CONTROL LEVEL; FUNCTION OF TIME; GENOTOXIC; GENOTOXICITIES; GENOTOXICITY; HUMAN LYMPHOCYTES; IRRADIATED SOLUTIONS; MINERALISATION; TOTAL ORGANIC CARBON; TREATMENT TIME; ULTRA-VIOLET; UV IRRADIATION;

IRRADIATION; PHOTOLYSIS; PYRIDINE;

ORGANIC CARBON;

2 HYDROXYPYRIDINE; PYRIDINOL; UNCLASSIFIED DRUG;

ALCOHOL; AQUEOUS SOLUTION; CONCENTRATION (COMPOSITION); GENOTOXICITY; MINERALIZATION; ORGANIC CARBON; ORGANIC COMPOUND; PHOTOLYSIS; ULTRAVIOLET RADIATION;

AQUEOUS SOLUTION; ARTICLE; CYTOKINESIS; GENOTOXICITY; HUMAN; HUMAN CELL; LYMPHOCYTE; MICRONUCLEUS; PHOTOLYSIS; TOTAL ORGANIC CARBON; ULTRAVIOLET C RADIATION; WASTE WATER MANAGEMENT;

HUMANS; LYMPHOCYTES; MICRONUCLEUS TESTS; MUTAGENS; PYRIDONES; ULTRAVIOLET RAYS; WATER POLLUTANTS, CHEMICAL;

EID: 82155166387     PISSN: 03043894     EISSN: 18733336     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2011.09.065     Document Type: Article

References (44)

1. Chemcyclopedia 95-The Manual of Commercially Available Chemicals, vol. 194 1994, 410. The American Chemical Society, Washington, DC. J.H. Kuney (Ed.).
2. Stapleton D.R., Konstantinou I.K., Karakitsou A., Hela D.G., Papadaki M. 2-Hydroxypyridine photolytic destruction by 254nm UV irradiation at different conditions. Chemosphere 2009, 77:1099-1105.
3. O'Loughlin E.J., Sims G.K., Traina1 S.J. Biodegradation of 2-methyl, 2-ethyl, and 2-hydroxypyridine by an Arthrobacter sp. isolated from subsurface sediment. Biodegradation 1999, 10:93-104.
4. R. Fisher, A. Lund, Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products, US Patent 2009/0137558, May 28 (2009).
5. Padoley K.V., Mudliar S.N., Pandey R.A. Heterocyclic nitrogenous pollutants in the environment and their treatment options - an overview. Bioresource Technol. 2008, 99:4029-4043.
6. Vieno N., Tuhkanen T., Kronberg L. Elimination of pharmaceuticals in sewage treatment plants. Water Res. 2007, 41:1001-1012.
7. Vlastos D., Skoutelis C.G., Theodoridis I.T., Stapleton D.R., Papadaki M.I. Genotoxicity study of photolytically treated 2-chloropyridine aqueous solutions. J. Hazard. Mater. 2010, 177:892-898.
8. 14C-imidacloprid in different compartments of Apis mellifera L. Pest Manag. Sci. 2004, 60:1056-1062.
9. Stapleton D.R., Konstantinou I.K., Hela D.G., Papadaki M. Photolytic removal and mineralisation of 2-halogenated pyridines. Water Res. 2009, 43:3964-3973.
10. Konstantinou I.K., Albanis T.A. Photocatalytic transformation of pesticides in aqueous titanium dioxide suspensions using artificial and solar light: intermediates and degradation pathways. Appl. Catal. B: Environ. 2003, 42:319-335.
11. 2-assisted photocatalytic degradation of azo dyes in aqueous solution: kinetic and mechanistic investigations-a review. Appl. Catal. B: Environ. 2004, 49:1-14.
12. Goto R., Kubota T., Ibuki Y., Kaji K., Goto A. Degradation of nonylphenol polyethoxylates by ultraviolet B irradiation and effects of their products on mammalian cultured cells. Toxicology 2004, 202:237-247.
13. OECD (draft), In Vitro Mammalian Cell Micronucleus Test (MNvit), OECD Guideline for Testing of Chemicals No. 487. OECD, Paris, 2010. Available from: (adopted: 22.07.10, accessed on 07.02.11). http://www.oecd.org/env/testguidelines.
14. Kirsch-Volders M., Decordier I., Elhajouji A., Plas G., Aardema M.J., Fenech M. In vitro genotoxicity testing using the micronucleus assay in cell lines, human lymphocytes and 3D human skin models. Mutagenesis 2011, 26:177-184.
15. MacLean-Fletcher S., Pollard T.D. Mechanism of action of cytochalasin B on actin. Cell 1980, 20:329-341.
16. Fenech M., Morley A.A. Measurement of micronuclei in lymphocytes. Mutat. Res. 1985, 147:29-36.
17. Fenech M. The cytokinesis-block micronucleus technique: A detailed description of the method and its application to genotoxicity studies in human populations. Mutat. Res. 1993, 285:35-44.
18. Fenech M. The advantages and disadvantages of the cytokinesis-block micronucleus method. Mutat. Res. 1997, 392:11-18.
19. Kirsch-Volders M., Sofuni T., Aardema M., Albertini S., Eastmond D., Fenech M., Ishidate M., Kirchner S., Lorge E., Morita T., Norppa H., Surrallés J., Vanhauwaert A., Wakata A. Report from the in vitro micronucleus assay group working. Mutat. Res. 2003, 540:153-163.
20. 2) decomposition of pyridines. J. Hazard. Mater. 2007, 146:640-645.
21. Stapleton R.D., Vlastos D., Skoutelis C.G., Papadaki M. Photolytic and photocatalytic diminution and preliminary genotoxicity studies of 2-chloropyridine. J. Adv. Oxid. Technol. 2008, 11:486-500.
22. Vlastos D., Moshou H., Epeoglou K. Evaluation of genotoxic effects of semicarbazide on cultured human lymphocytes and rat bone marrow. Food Chem. Toxicol. 2010, 48:209-214.
23. Surrallés J., Carbonell E., Marcos R., Degrassi F., Antoccia A., Tanzarella C. A collaborative study on the improvement of the micronucleus test in cultured human lymphocytes. Mutagenesis 1992, 7:407-410.
24. Papapaulou P., Vlastos D., Stephanou G., Demopoulos N.A. Linuron cytogenetic activity on human lymphocutes treated in vitro. Evaluation of clastogenic and aneugenic potential using Cytokinesis Block Micronucleus Assay in combination with Fluorescence in situ Hybridization (FISH). Fresen. Environ. Bull. 2001, 10:421-437.
25. Vlastos D., Stephanou G. Effects of cetirizine dihydrochloride on human lymphocytes in vitro: micronucleus induction. Evaluation of clastogenic and aneugenic potential using CREST and FISH assays. Arch. Dermatol. Res. 1998, 290:312-318.
26. Fenech M., Chang W.P., Kirsch-Volders M., Holland N., Bonassi S., Zeiger E. HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutat. Res. 2003, 534:65-75.
27. Surrallés J., Xamena N., Creus A., Catalan J., Norppa H., Marcos R. Induction of micronuclei by five pyrethroid insecticides in whole-blood and isolated human lymphocyte cultures. Mutat. Res. 1995, 341:169-184.
28. Surrallés J., Natarajan A.T. Human lymphocytes micronucleus assay in Europe. An international survey. Mutat. Res. 1997, 392:165-174.
29. Abou-Eisha A., Marcos R., Creus A. Genotoxicity studies on the antimicrobial drug sulfamethoxazole in cultured human lymphocytes. Mutat. Res. 2004, 564:51-56.
30. n (n=0-2) in the ground and excited states. J. Phys. Chem. A 2005, 109:3983-3990.
31. Hashimoto K., Nakajima Y., Matsumura S., Chatani F. An in vitro micronucleus assay with size-classified micronucleus counting to discriminate aneugens from clastogens. Toxicol. In Vitro 2010, 24:208-216.
32. Zimmermann F.K., Henning J.H., Scheel I., Oehler M. Genetic effects induced by pyridines derivatives. Mutat. Res. 1986, 163:23-31.
33. Claxton L.D., Dearfield K.L., Spanggord R.G., Riccio E.S., Mortelsman K. Comparative mutagenicity of halogenated pyridines. Mutat. Res. 1987, 176:185-198.
34. Dearfield K.L., Harrington-Brock K., Doerr C.L., Parker L., Moore M.M. Genotoxicity of three pyridine compounds to L5178Y mouse lymphoma cells. Mutat. Res. 1993, 301:57-63.
35. Anuszewka E.L., Koziorowska J.H. Role of pyridine N-oxide in the cytotoxicity and genotoxicity of chloropyridines. Toxicol. In Vitro 1995, 9:91-94.
36. Iba M.M., Fung J., Giannone J.V., Okey A.B. Comparative induction of CYP1A1 expression by pyridine and its metabolites. Arch. Biochem. Biophys. 2000, 378:299-310.
37. Wei C., Caccavale R.J., Weyand E.H., Chen S., Iba M.M. Induction of CYP1A1 and CYP1A2 expressions by prototypic and atypical inducers in the human lung. Cancer Lett. 2002, 178:25-36.
38. Iba M.M., Nguyen T., Fung J. CYP1A1 induction by pyridine and its metabolites in HepG2 cells. Arch. Biochem. Biophys. 2002, 404:326-334.
39. Nelson D.R., Koymans L., Kamataki T., Stegeman J.J., Feyereisen R., Waxman D.J., Waterman M.R., Gotoh O., Coon M.J., Estabrook R.W., Gunsalus I.C., Nebert D.W. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996, 6:1-42.
40. Shimada T., Yun C.-H., Yamazaki H., Gautier J.-C., Beaune P.H., Guengerich F.P. Characterization of human lung microsomal cytochrome P450 1A1 and its role in the oxidation of chemical carcinogens. Mol. Pharmacol. 1992, 41:856-864.
41. Antilla S., Hietanen E., Vainio H., Camus A.M., Gelboin H.V., Park S.S., Heikella L., Karkalainen A., Bartsch H. Comparative induction of CYP1A1 expression by pyridine and its metabolites. Int. J. Cancer 1991, 47:681-685.
42. Denissenko M.F., Pao A., Tang M., Pfeifer G.P. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 1996, 274:430-432.
43. Carlson G.P. Comparison of the effects of pyridine and its metabolites on rat liver and kidney. Toxicol. Lett. 1996, 85:173-178.
44. Huq F., Tayyem H., Beale P., Yu J.Q. Studies on the activity of three palladium(II) compounds of the form: trans-PdL2Cl2 where L=2-hydroxypyridine, 3-hydroxypyridine, and 4-hydroxypyridine. J. Inorg. Biochem. 2007, 101:30-35.